Oncostatin M stimulates c-Fos to bind a transcriptionally responsive AP-1 element within the tissue inhibitor of metalloproteinase-1 promoter.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 9478976)

Published in J Biol Chem on February 27, 1998

Authors

F M Botelho1, D R Edwards, C D Richards

Author Affiliations

1: Molecular Virology and Immunology Program, Department of Pathology, McMaster University, Hamilton, Ontario L8N 3Z5, Canada.

Articles citing this

Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells. Mol Cell Biol (1999) 1.31

Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. J Clin Invest (2000) 1.23

Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections? EMBO J (2002) 1.15

Leptin increases tissue inhibitor of metalloproteinase I (TIMP-1) gene expression by a specificity protein 1/signal transducer and activator of transcription 3 mechanism. Mol Endocrinol (2006) 1.09

Protein kinase C isoforms zeta and iota mediate collagenase expression and cartilage destruction via STAT3- and ERK-dependent c-fos induction. J Biol Chem (2010) 1.08

Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus. Clin Exp Immunol (2004) 1.04

Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am J Pathol (2000) 0.99

Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand. Am J Pathol (2002) 0.91

Oncostatin M induced alpha1-antitrypsin (AAT) gene expression in Hep G2 cells is mediated by a 3' enhancer. Biochem J (2002) 0.85

Novel targets for Spinal Cord Injury related neuropathic pain. Ann Neurosci (2011) 0.79

Articles by these authors

(truncated to the top 100)

Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci (2001) 3.71

MicroRNAs and the hallmarks of cancer. Oncogene (2006) 2.55

Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol (1988) 2.37

Matrix metalloproteinases and diseases of the CNS. Trends Neurosci (1998) 2.24

Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem (1994) 1.99

Electrical activity observed in guinea-pig olfactory cortex maintained in vitro. J Physiol (1968) 1.83

Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci (1999) 1.81

Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry (1995) 1.81

On the mechanism of barbiturate anaesthesia. J Physiol (1972) 1.75

IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest (2000) 1.74

Transcriptional regulation of two serum-induced RNAs in mouse fibroblasts: equivalence of one species to B2 repetitive elements. Mol Cell Biol (1985) 1.73

Calcium, magnesium and the electrical activity of guinea-pig olfactory coex in vitro. J Physiol (1970) 1.72

Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer (1999) 1.71

Signalling and superinduction. Nature (1991) 1.70

Degenerate perturbations of protein structure as the mechanism of anaesthetic action. Nature (1979) 1.68

The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum (2002) 1.52

Anaesthetics depress the sensitivity of cortical neurones to L-glutamate. Br J Pharmacol (1976) 1.51

Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett (1997) 1.49

An electrophysiological and neuroanatomical study of the medial prefrontal cortical projection to the midbrain raphe nuclei in the rat. Neuroscience (1998) 1.47

Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues. Br J Cancer (2005) 1.45

Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol (1998) 1.38

Gene expression during the mammalian cell cycle. Biochim Biophys Acta (1986) 1.37

Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. Osteoarthritis Cartilage (2001) 1.36

Murine tissue inhibitor of metalloproteinases-4 (Timp-4): cDNA isolation and expression in adult mouse tissues. FEBS Lett (1997) 1.36

Anchorage-independent colony growth of pulmonary fibroblasts derived from fibrotic human lung tissue. J Clin Invest (1994) 1.35

A novel method for absolute calibration of intracellular pH indicators. Pflugers Arch (1989) 1.35

Potentiation and depression of synaptic transmission in the olfactory cortex of the guinea-pig. J Physiol (1972) 1.35

Cancer. Proteases--invasion and more. Nature (1998) 1.34

Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J Immunol (1999) 1.32

Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations. Genes Dev (1990) 1.32

Characterization of the mouse met proto-oncogene. Oncogene (1988) 1.31

Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther (1993) 1.29

Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood (1999) 1.26

A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: evidence for inducible and constitutive transcripts. Nucleic Acids Res (1986) 1.25

Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane. Blood (1999) 1.23

Na+/H+ exchange is the major mechanism of pH regulation in cultured sympathetic neurons: measurements in single cell bodies and neurites using a fluorescent pH indicator. Neuroscience (1987) 1.20

Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma. Br J Cancer (2006) 1.19

Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues. Mol Pathol (2001) 1.19

Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway. Lack of evidence for STAT 6 involvement. J Biol Chem (2000) 1.19

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period. Dev Genet (1997) 1.18

TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol (2001) 1.16

Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum (2003) 1.15

Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer (1992) 1.15

The action of ether and methoxyflurane on synaptic transmission in isolated preparations of the mammalian cortex. J Physiol (1975) 1.13

Electrical activity observed in guinea-pig olfactory cortex maintained in vitro and its modification by changes in the ionic composition of the bathing medium. J Physiol (1968) 1.13

Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis. Arthritis Rheum (2006) 1.10

ERK5 signalling in prostate cancer promotes an invasive phenotype. Br J Cancer (2011) 1.10

The effect of bilayer thickness and n-alkanes on the activity of the (Ca2+ + Mg2+)-dependent ATPase of sarcoplasmic reticulum. J Biol Chem (1981) 1.09

Characterisation of the calcium responses to histamine in capsaicin-sensitive and capsaicin-insensitive sensory neurones. Neuroscience (2002) 1.09

Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas. Blood (1991) 1.08

Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species. Biochem J (2001) 1.08

The actions of volatile anaesthetics on synaptic transmission in the dentate gyrus. J Physiol (1975) 1.08

Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. Development (1995) 1.08

Intra-articular IL-10 gene transfer regulates the expression of collagen-induced arthritis (CIA) in the knee and ipsilateral paw. Clin Exp Immunol (2000) 1.07

Changes in free-calcium levels and pH in synaptosomes during transmitter release. Biochim Biophys Acta (1984) 1.06

Specific release of endogenous glutamate from piriform cortex stimulated in vitro. Brain Res (1976) 1.06

Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases. Br J Cancer (2000) 1.06

On the mechanism of halothane anaesthesia. J Physiol (1973) 1.06

Developmental expression of tissue inhibitor of metalloproteinase (TIMP) RNA. Development (1989) 1.04

Interleukin-1 in combination with oncostatin M up-regulates multiple genes in chondrocytes: implications for cartilage destruction and repair. Arthritis Rheum (2006) 1.04

Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas. Br J Cancer (2001) 1.03

Differential regulation of TIMP-1 and TIMP-2 mRNA expression in normal and Ha-ras-transformed murine fibroblasts. Gene (1992) 1.03

Lymph node metastases from glioblastoma multiforme. AJNR Am J Neuroradiol (1997) 1.03

Spontaneous immortalization of mouse embryo cells: strain differences and changes in gene expression with particular reference to retroviral gag-pol genes. Exp Cell Res (1991) 1.03

Actions of general anaesthetics on synaptic transmission in the CNS. Br J Anaesth (1983) 1.01

Close relationship of the major excreted protein of transformed murine fibroblasts to thiol-dependent cathepsins. Cancer Res (1986) 1.01

Chloride fluxes in crab muscle fibres. J Physiol (1969) 1.01

Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral tegmental area in vitro. Exp Brain Res (1994) 1.00

Additive and non-additive effects of mixtures of short-acting intravenous anaesthetic agents and their significance for theories of anaesthesia. Br J Pharmacol (1981) 1.00

Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br J Cancer (1996) 1.00

A study of mitochondrial and nuclear transcription with cloned cDNA probes. Changes in the relative abundance of mitochondrial transcripts after stimulation of quiescent mouse fibroblasts. Exp Cell Res (1985) 1.00

Construction of recombinant human type 5 adenoviruses expressing rodent IL-6 genes. An approach to investigate in vivo cytokine function. J Immunol (1993) 1.00

Long-term potentiation at excitatory amino acid synapses on midbrain dopamine neurons. Neuroreport (1999) 1.00

Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro. Arthritis Rheum (1997) 1.00

The action of anaesthetics on synaptic transmission. Gen Pharmacol (1978) 1.00

A superfusion chamber suitable for maintaining mammalian brain tissue slices for electrical recording [proceedings]. Br J Pharmacol (1977) 0.99

Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am J Pathol (2000) 0.99

Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells. Br J Haematol (1999) 0.99

Excitatory and inhibitory synaptic mechanisms in anaesthesia. Br J Anaesth (1993) 0.98

The selective depression of evoked cortical EPSPs by pentobarbitone. J Physiol (1971) 0.98

Apical endocytosis in outer hair cells of the mammalian cochlea. Eur J Neurosci (2004) 0.98

Banking of fresh-frozen prostate tissue: methods, validation and use. BJU Int (2003) 0.98

Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Diagn Mol Pathol (1993) 0.97

Characterization of a cDNA clone encoding murine mitogen-regulated protein: regulation of mRNA levels in mortal and immortal cell lines. Mol Cell Biol (1985) 0.97

Improved design of riboprobes from pBluescript and related vectors for in situ hybridization. Biotechniques (1993) 0.97

Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines. FEBS Lett (1999) 0.97

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 are key regulators of extracellular matrix degradation by mouse embryos. Biol Reprod (2001) 0.96

Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas. Neuro Oncol (2000) 0.96

Prostaglandin E2 enhances interleukin 8 (IL-8) and IL-6 but inhibits GMCSF production by IL-1 stimulated human synovial fibroblasts in vitro. J Rheumatol (1996) 0.96

Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1. Biochem J (1997) 0.95

Extracellular matrix and matrix metalloproteinases in sciatic nerve. J Neurosci Res (2003) 0.95

Electrical responses in brain samples. Nature (1967) 0.94

The distribution of vasopressin and oxytocin in the hypothalamoneurohypophysial system of the guinea-pig. Br J Pharmacol (1973) 0.94

Temporal and spatial expression of tissue inhibitors of metalloproteinases during the natural ovulatory cycle of the mouse. Biol Reprod (1996) 0.93

The action of pentobarbitone on stimulus-secretion coupling in adrenal chromaffin cells. Br J Pharmacol (1987) 0.93

The effects of tetrodotoxin on the evoked potentials of the guinea-pig prepiriform cortex. Brain Res (1971) 0.93

Some experiments with in vitro hippocampal slices. J Physiol (1971) 0.93

Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures. Hepatology (1993) 0.92

Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC) compared to normal lung: correlation of MMP-14 mRNA expression and proteolytic activity. Eur J Cancer (2007) 0.92

Comparison of platelet storage in PL146 and PL732 plastic packs: preliminary in vitro studies. J Clin Pathol (1982) 0.92